USPTO serial 86155581
IMMUNOCLIN
Reviewed by CopyMark Law Group
Reg. 4655372Status 710
- Filing date
- Status date
- Registration date
- Dec 16, 2014
- Examiner
- POLLACK, ALISON FRIEDBERG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with IMMUNOCLIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nancy J. Flint
Nancy J. Flint NANCY J FLINT ATTORNEY AT LAW P A1580 Sawgrass Corporate ParkwaySuite 130Sunrise, FL 33323Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing information in the field of predictive medical tests for medical research purposes; providing information in the field of compiling and presenting results of predictive medical tests for medical research purposes; providing information in the field of compiling and presenting results of diagnostic medical tests for medical research purposes; providing medical and scientific research information in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies; providing information in the field of chemical preparations for testing blood for medical research purposes; providing information in the field of vaccines and sera for medical research purposes; providing information in the field of predictive medical tests for medical research purposes via the internet; providing information in the field of compiling and presenting results of predictive medical tests for medical research purposes via the internet; providing information in the field of compiling and presenting results of diagnostic medical tests for medical research purposes via the internet; providing medical and scientific research information in the field of pharmaceutical preparations via the internet; providing medical and scientific research information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies via the internet; providing information in the field of chemical preparations for testing blood for medical research purposes via the internet; providing information in the field of vaccines and sera via the internet for medical research purposes; providing technical information in the field of predictive medical tests for medical research purposes; providing technical information in the field of compiling and presenting results of predictive medical tests for medical research purposes; providing technical information in the field of compiling and presenting results of diagnostic medical tests for medical research purposes; providing medical and scientific research technical information in the field of pharmaceutical preparations; providing medical and scientific research technical information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies; providing technical information in the field of chemical preparations for testing blood for medical research purposes; providing technical information in the field of vaccines and sera for medical research purposes | SECTION 8 - CANCELLED | Dec 13, 2013 |
| 044 | Providing information in the field of immunopathology of various diseases and their treatment and prevention; providing information in the field of predictive medical tests for diagnostic or treatment purposes; providing information in the field of compiling and presenting results of predictive medical tests directly to the patient for diagnostic purposes; providing information in the field of diagnostic medical tests; providing information in the field of compiling and presenting results of diagnostic medical tests directly to the patient for diagnostic purposes; providing information in the field of dispensing pharmaceutical preparations; providing information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies; providing information in the field of chemical preparations for testing blood for medical diagnostic or treatment purposes; providing information in the field of diagnostic and testing materials for medical use; providing information in the field of immunopathology of various diseases and their treatment and prevention via the internet; providing information in the field of predictive medical tests for diagnostic or treatment purposes via the internet; providing information in the field of compiling and presenting results of predictive medical tests directly to the patient for diagnostic purposes via the internet; providing information in the field of diagnostic medical tests via the internet; providing information in the field of compiling and presenting results of diagnostic medical tests directly to the patient for diagnostic purposes via the internet; providing information in the field of dispensing pharmaceutical preparations via the internet; providing information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies via the internet; providing information in the field of chemical preparations for testing blood for medical diagnostic or treatment purposes via the internet; providing information in the field of diagnostic and testing materials for medical use via the internet; providing technical information in the field of immunopathology of various diseases and their treatment and prevention; providing technical information in the field of predictive medical tests for diagnostic or treatment purposes; providing technical information in the field of compiling and presenting results of predictive medical tests directly to the patient for diagnostic purposes; providing technical information in the field of diagnostic medical tests; providing technical information in the field of compiling and presenting results of diagnostic medical tests directly to the patient for diagnostic purposes; providing technical information in the field of dispensing pharmaceutical preparations; providing technical information in the field of pharmaceutical products for diagnosis and treatment of immune system deficiencies; providing technical information in the field of chemical preparations for testing blood for medical diagnostic or treatment purposes; providing technical information in the field of diagnostic and testing materials for medical use | SECTION 8 - CANCELLED | Dec 13, 2013 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 23, 2021 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 16, 2019 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 16, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 30, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 30, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 23, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 21, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 21, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 21, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 21, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 7, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Aug 5, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 22, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 22, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 7, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 14, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 13, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 3, 2014 | NWAP | NEW APPLICATION ENTERED | — |